Surgical treatment for RSVA carries an acceptably low operative risk and long-term freedom from death and reoperation. Surgical approach must be chosen according to the ruptured chamber and associated lesions. Patch repair of RSVA must be preferred.
IntroductionOptimal surgical approach for the treatment of resectable lung cancer
accompanied by coronary artery disease (CAD) remains a contentious issue. In
this study, we present our cases that were operated simultaneously for
concurrent lung cancer and CAD.MethodsSimultaneous off-pump coronary artery bypass surgery (OPCABG) and lung
resection were performed on 10 patients in our clinic due to lung cancer
accompanied by CAD. Demographic features of patients, operation data and
postoperative results were evaluated retrospectively.ResultsMean patient age was 63.3 years (range 55-74). All patients were male. Six
cases of squamous cell carcinoma, three of adenocarcinoma and one case of
large cell carcinoma were diagnosed. Six patients had single-vessel CAD and
4 had two-vessel CAD. Three patients underwent OPCABG at first and then lung
resection. The types of resections were one right pneumonectomy, three right
upper lobectomies, one right lower lobectomy, three left upper lobectomies,
and two left lower lobectomies. Reoperation was performed in one patient due
to hemorrhage. One patient developed intraoperative contralateral tension
pneumothorax. One patient died due to acute respiratory distress syndrome at
the early postoperative period.ConclusionSimultaneous surgery is a safe and reliable option in the treatment of
selected patients with concurrent CAD and operable lung cancer.
IntroductionDetermining operative mortality risk is mandatory for adult cardiac surgery. Patients should be informed about the operative risk before surgery. There are some risk scoring systems that compare and standardize the results of the operations. These scoring systems needed to be updated recently, which resulted in the development of EuroSCORE II. In this study, we aimed to validate EuroSCORE II by comparing it with the original EuroSCORE risk scoring system in a group of high-risk octogenarian patients who underwent coronary artery bypass grafting (CABG).Material and methodsThe present study included only high-risk octogenarian patients who underwent isolated coronary artery bypass grafting in our center between January 2000 and January 2010. Redo procedures and concomitant procedures were excluded. We compared observed mortality with expected mortality predicted by EuroSCORE (logistic) and EuroSCORE II scoring systems.ResultsWe considered 105 CABG operations performed in octogenarian patients between January 2000 and January 2010. The mean age of the patients was 81.43 ± 2.21 years (80-89 years). Thirty-nine (37.1%) of them were female. The two scales showed good discriminative capacity in the global patient sample, with the AUC (area under the curve) being higher for EuroSCORE II (AUC 0.772, 95% CI: 0.673-0.872). The goodness of fit was good for both scales.ConclusionsWe conclude that EuroSCORE II has better AUC (area under the ROC curve) compared to the original EuroSCORE, but both scales showed good discriminative capacity and goodness of fit in octogenarian patients undergoing isolated coronary artery bypass grafting.
Pericardial constriction may develop a long time after the initial presentation of certain neoplastic diseases, and the prognosis after pericardiectomy is poor.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.